Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Chubb
Deloitte
Colorcon
Fish and Richardson
Farmers Insurance
Cantor Fitzgerald
Mallinckrodt
Dow
Queensland Health

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022161

« Back to Dashboard

NDA 022161 describes LEXISCAN, which is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are seventeen patents protecting this drug and one Paragraph IV challenge. Additional details are available on the LEXISCAN profile page.

The generic ingredient in LEXISCAN is regadenoson. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the regadenoson profile page.
Summary for 022161
Tradename:LEXISCAN
Applicant:Astellas
Ingredient:regadenoson
Patents:17
Pharmacology for NDA: 022161
Mechanism of ActionAdenosine Receptor Agonists
Suppliers and Packaging for NDA: 022161
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEXISCAN regadenoson SOLUTION;INTRAVENOUS 022161 NDA Astellas Pharma US, Inc. 0469-6501 0469-6501-89 5 mL in 1 SYRINGE, PLASTIC (0469-6501-89)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength0.4MG/5ML (0.08MG/ML)
Approval Date:Apr 10, 2008TE:RLD:Yes
Regulatory Exclusivity Expiration:Jan 17, 2020
Regulatory Exclusivity Use:
Patent:➤ SubscribePatent Expiration:Apr 10, 2022Product Flag?YSubstance Flag?YDelist Request?
Patented Use:METHOD FOR STIMULATING CORONOARY VASODILATION FOR PURPOSES OF IMAGING THE HEART
Patent:➤ SubscribePatent Expiration:Jun 22, 2019Product Flag?YSubstance Flag?YDelist Request?
Patented Use:METHOD FOR STIMULATING CORONOARY VASODILATION FOR PURPOSES OF IMAGING THE HEART

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Covington
Teva
Harvard Business School
Julphar
Mallinckrodt
Healthtrust
UBS
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot